Contineum Therapeutics, Inc. Class A Common StockCTNMNASDAQ
Loading
Year-over-year operating income growth rate
Latest
-14.62%
↓ 114% vs avg
Percentile
P33
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
102.33%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -14.62% |
| Q3 2025 | 16.59% |
| Q2 2025 | 1.15% |
| Q1 2025 | -121.37% |
| Q4 2024 | 753.16% |
| Q3 2024 | -18.55% |
| Q2 2024 | -10.21% |
| Q1 2024 | -2.63% |
| Q4 2023 | -19.92% |
| Q3 2023 | -120.72% |
| Q2 2023 | 861.23% |
| Q1 2023 | 6.13% |
| Q4 2022 | 0.00% |